Interesting HTAN study to understand human cancer development in spatial manner. Potentially could be helpful to understanding many other diseases in future.
Phaedon Institute
Education
San Francisco Bay Area, CA 593 followers
Transmuting Awareness of Longevity & Aging Sciences
About us
The Phaedon Institute is a think-tank organization that operates with the mission of supporting and enabling effective and sustainable growth in the field of aging and longevity sciences. Phaedon Institute Is A Tax-Exempt 501(C)(3) Scientific Non-Profit Charity Organization.
- Website
-
https://www.phaedon.institute
External link for Phaedon Institute
- Industry
- Education
- Company size
- 2-10 employees
- Headquarters
- San Francisco Bay Area, CA
- Type
- Nonprofit
- Founded
- 2022
- Specialties
- longevity, therapeutics, aging, and senescence
Locations
-
Primary
Get directions
San Francisco Bay Area, CA, US
Employees at Phaedon Institute
Updates
-
Phaedon Institute reposted this
At the Phaedon Institute we are excited to share the report of the SenoTherapeutics Summit that was organized last fall at the Buck Institute for Research on Aging. You can read the paper now published on Nature Portfolio journal npj #Aging by the Summit chairs Dr. Marco Quarta, our President, and Dr. Marco Demaria, our Chairman of the SAB.
Check out the last paper on the journal Nature Portfolio #npjAging by Marco Demaria and myself, with our report on the #SenoTherapeuticsSummit organized by Phaedon Institute. The field of therapeutics targeting cellular senescence has been growing over the years, and is now maturing to a sophisticated science and echosistem around it leading to a large portfolio of novel therapeutic opportunities up and coming. The message from leading key opinion leaders, academy, industry, Big Pharma and Venture Capitals who gathered at the Summit to share their experience on the stage, is loud and clear: cellular senescence and SenoTherapeutics are the future of medicine, happening now. Big thank you to all speakers, organizers and contributors to the success of the SenoTherapeutics summit, including: Peter Adams, Maddalena Adorno, Andrea Alimonti, Terence Burns, Timothy Cash, Simone Fantaccini, MD, MBA, Antonio Filareto, Farah Gerdes, Vassilis Gorgoulis, Myriam Gorospe, William Greene, Aubrey de Grey, Eiji Hara, Yasuaki Hashimoto, LaTonya Hickson MDm Christine Yuan HUANG, Jun-Wei Brendan Hughes, Peter de Keizer, Sundeep Khosla, Morten Scheibye-Knudsen, James Kirkland, John Lewis, Scott Lowe, Robin Mansukhani, Kelsey Moody, PhD, MBA, Alexander A. Morgan, MD PhD, Mahdi Moqri, Ronjon Nag, Laura Neidernhofer, Paul Robbins, Mike (Przemyslaw) Sapieha, Vittorio Sebastiano, Clemens Schmitt, Amit Sharma, Maximilian Unfried, Tom Weldon, Benjamin Yaden, Ikram Khan, Elena Itskovich, PhD, Akshay Pujari, Francesco Neri, Daria Timonina
On the past, present and future of senotherapeutics - npj Aging
nature.com
-
At the Phaedon Institute we are excited to share the report of the SenoTherapeutics Summit that was organized last fall at the Buck Institute for Research on Aging. You can read the paper now published on Nature Portfolio journal npj #Aging by the Summit chairs Dr. Marco Quarta, our President, and Dr. Marco Demaria, our Chairman of the SAB.
Check out the last paper on the journal Nature Portfolio #npjAging by Marco Demaria and myself, with our report on the #SenoTherapeuticsSummit organized by Phaedon Institute. The field of therapeutics targeting cellular senescence has been growing over the years, and is now maturing to a sophisticated science and echosistem around it leading to a large portfolio of novel therapeutic opportunities up and coming. The message from leading key opinion leaders, academy, industry, Big Pharma and Venture Capitals who gathered at the Summit to share their experience on the stage, is loud and clear: cellular senescence and SenoTherapeutics are the future of medicine, happening now. Big thank you to all speakers, organizers and contributors to the success of the SenoTherapeutics summit, including: Peter Adams, Maddalena Adorno, Andrea Alimonti, Terence Burns, Timothy Cash, Simone Fantaccini, MD, MBA, Antonio Filareto, Farah Gerdes, Vassilis Gorgoulis, Myriam Gorospe, William Greene, Aubrey de Grey, Eiji Hara, Yasuaki Hashimoto, LaTonya Hickson MDm Christine Yuan HUANG, Jun-Wei Brendan Hughes, Peter de Keizer, Sundeep Khosla, Morten Scheibye-Knudsen, James Kirkland, John Lewis, Scott Lowe, Robin Mansukhani, Kelsey Moody, PhD, MBA, Alexander A. Morgan, MD PhD, Mahdi Moqri, Ronjon Nag, Laura Neidernhofer, Paul Robbins, Mike (Przemyslaw) Sapieha, Vittorio Sebastiano, Clemens Schmitt, Amit Sharma, Maximilian Unfried, Tom Weldon, Benjamin Yaden, Ikram Khan, Elena Itskovich, PhD, Akshay Pujari, Francesco Neri, Daria Timonina
On the past, present and future of senotherapeutics - npj Aging
nature.com